Federal Circuit Holds That Claims of a Patent Asserted During a Patent Term Extension Are Not Infringed by the Carboxylic Acid Derivative of an FDA-Approved Ester Containing Drug – JD Supra

Federal Circuit Holds That Claims of a Patent Asserted During a Patent Term Extension Are Not Infringed by the Carboxylic Acid Derivative of an FDA-Approved Ester Containing Drug  JD Supra